We are live on ! Find out more
EAM

Empery Asset Management Portfolio holdings

AUM $86.5M
This Fund
S&P 500
This Quarter Est. Return
-34.27%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$18.5M
AUM Growth
-$2.81M
Cap. Flow
+$6.2M
Cap. Flow %
33.6%
Top 10 Hldgs %
79.94%
Holding
88
New
11
Increased
–
Reduced
13
Closed
13

Top Buys

Rank Stock Value
1
MMAT
Meta Materials Inc. Common Stock
MMAT
+$6.52M
2
SLS icon
SELLAS Life Sciences
SLS
+$2.72M
3
ETNB
89bio
ETNB
+$1.21M
4
APLT
Applied Therapeutics
APLT
+$1.11M
5
SKYAW
SkyAI Inc
SKYAW
+$343K

Top Sells

Rank Stock Value
1
BRCC.WS
BRC Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock a
BRCC.WS
+$1.2M
2
SBFM
Sunshine Biopharma
SBFM
+$1.1M
3
VLNS
The Valens Company, Inc. Common Shares
VLNS
+$688K
4
AIOS
AIOS Tech
AIOS
+$658K
5
STLN
Starling Oncology
STLN
+$504K

Sector Composition

Rank Sector Weight
1 Miscellaneous 48.77%
2 Healthcare 25.83%
3 Technology 25.02%
4 Consumer Staples 0.38%
5 Energy 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMPP icon
76
Imperial Petroleum
IMPP
$229M
– –
-3,833
Closed -$83K
INM icon
77
InMed Pharmaceuticals
INM
$7.64M
– –
-123
Closed -$58K
AIOS
78
AIOS Tech
AIOS
$54.3M
– –
-3,363
Closed -$658K
RFL icon
79
Rafael Holdings
RFL
$123M
– –
-12,151
Closed -$30K
SBFM
80
Sunshine Biopharma
SBFM
$4.92M
– –
-23
Closed -$1.1M
SLNO
81
DELISTED
Soleno Therapeutics
SLNO
– –
-93,427
Closed -$313K
STLN
82
Starling Oncology
STLN
$646M
– –
-70,733
Closed -$504K
VLNS
83
DELISTED
The Valens Company, Inc. Common Shares
VLNS
– –
-400,000
Closed -$688K
STAB
84
DELISTED
Statera Biopharma, Inc. Common Stock
STAB
– –
-333,016
Closed -$105K
AGTC
85
DELISTED
Applied Genetic Technologies Corporation
AGTC
– –
-100,000
Closed -$107K
CALA
86
DELISTED
Calithera Biosciences, Inc
CALA
– –
-38,796
Closed -$313K
IMRNW
87
DELISTED
Immuron Limited Warrants
IMRNW
– –
-46,161
Closed -$4K
BRCC.WS
88
DELISTED
BRC Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock a
BRCC.WS
– –
-269,212
Closed -$1.2M
1 2 3
4

Similar funds

BCM
Beaumont Capital Management Boston, Massachusetts $86.4M AUM 20.04% 1-Year Est. Return
TI
Truxt Investmentos Rio De Janeiro, Brazil $86.6M AUM
LCM
LDR Capital Management New York $86.7M AUM 16.32% 1-Year Est. Return
AA
Ascent Advisors Mankato, Minnesota $86.7M AUM
YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
CL
CPWA LLC Hood River, Oregon $86.1M AUM
TWM
Tripletail Wealth Management Orlando, Florida $86.9M AUM 39.01% 1-Year Est. Return
BI
Bradyco Inc Cambridge, Massachusetts $87.2M AUM 8.85% 1-Year Est. Return

Empery Asset Management's Q2 2022 Portfolio in Review

As of Q2 2022, Empery Asset Management held 88 positions worth $18.5M, down 13% from $21.3M the previous quarter. Its ten largest holdings account for 80% of the portfolio.

Empery Asset Management deployed $6.2M of net new capital in Q2 2022, opening 11 new positions. Its largest new stake was Meta Materials Inc. Common Stock: 43,706 shares worth $4.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 75% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Sunshine Biopharma Inc Warrant, an estimated $389K trimmed.

  • Empery Asset Management's largest Q2 2022 buy was Meta Materials Inc. Common Stock: 43,706 shares worth $4.5M.
  • Empery Asset Management's biggest Q2 2022 reduction was Sunshine Biopharma Inc Warrant, cutting an estimated $389K.
  • Empery Asset Management fully exited BRC Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock a in Q2 2022, selling an estimated $1.2M.
  • Empery Asset Management's ten largest holdings make up 80% of its $18.5M portfolio in Q2 2022.
  • Empery Asset Management opened 11 new positions and closed 13 in Q2 2022.
  • Empery Asset Management's portfolio value fell 13% quarter-over-quarter to $18.5M.

Based on Empery Asset Management's 13F filing for Q2 2022, filed 12 Aug 2022.